Expert Discusses Next Steps With Immunotherapy, Targeted Agents in NSCLC – OncLive
OncLive |
Expert Discusses Next Steps With Immunotherapy, Targeted Agents in NSCLC
OncLive There is specific scientific rationale to support the combination of chemotherapy with immunotherapy, and there is a large body of literature suggesting that these combinations may be beneficial. The final judgment will be made by the FDA, but this … |
